Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care. Ann Surg Oncol 2022 Apr;29(4):2176-2180
Date
06/08/2021Pubmed ID
34097159DOI
10.1245/s10434-021-10217-5Scopus ID
2-s2.0-85107782600 (requires institutional sign-in at Scopus site) 29 CitationsAbstract
The Society of Surgical Oncology is committed to reducing health disparities adversely affecting sexual and gender minorities. Transgender persons represent a socially disadvantaged group who frequently experience discrimination and receive disparate care, resulting in suboptimal cancer outcomes. The rate of breast cancer development in transgender individuals differs from rates observed in their cisgender counterparts, however there is little evidence to quantify these differences and guide evidence-based screening and prevention. There is no consensus for breast cancer screening guidelines in transgender patients. In this review, we discuss barriers to equitable breast cancer care, risk factors for breast cancer development, and existing data to support breast cancer screening in transgender men and women.
Author List
Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SLAuthors
Callisia N. Clarke MD Chief, Associate Professor in the Surgery department at Medical College of WisconsinChandler S. Cortina MD Assistant Professor in the Surgery department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Breast NeoplasmsEarly Detection of Cancer
Female
Humans
Male
Risk Factors
Transgender Persons
Vulnerable Populations
